Skip to main content
. 2015 Jul 15;7(7):1260–1270.

Figure 3.

Figure 3

Immunological characterization of Der f 27. A. Immunobloting analysis of specific IgE reactivity to allergen r-Der f 27 in the serum from r-Der f 27 SPT positive individuals. Lanes 1-3 indicatethe IgE positive serum from allergic subjects. Lane 4 indicatescontrol serum from healthy subjects using as negative controls. B. The specific IgE reactivity to allergen r-Der f 27 by ELISA. P1-P3, the serum from r-Der f 27 positive patients; C1 and C2, the serum from healthy control subjects.